AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17597089 — intervention group
Group type: COMPARATOR
Intervention: ECC rinse without unfractionated heparin (UFH)
Number of subjects: 10
Study 15302734 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control strategy
Number of subjects: 205
Study 15302734 — intervention group
Group type: COMPARATOR
Intervention: Rate control group
Number of subjects: 205
Study 15302734 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control group
Number of subjects: 205
Study 15302734 — intervention group
Group type: COMPARATOR
Intervention: Composite end point (all-cause mortality, thromboembolic events, major bleeding)
Number of subjects: 205
Study 11462953 — intervention group
Group type: EXPERIMENTAL
Intervention: Pouch and Roux-en-Y (PR; n = 15)
Number of subjects: 30
Study 11462953 — intervention group
Group type: COMPARATOR
Intervention: Pouch and interposition (PI; n = 15)
Number of subjects: 30
Study 9664650 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive mood
Number of subjects: 0
Study 9664650 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood
Number of subjects: 0
Study 8002117 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid ingestion (F) - 400 ml bolus of 20 mmol/l NaCl immediately before exercise and 120 ml feedings every 10 min during the first 50 min of exercise.
Number of subjects: 6
Study 8002117 — intervention group
Group type: COMPARATOR
Intervention: No fluid ingestion (NF) - no fluid ingested before or during exercise.
Number of subjects: 6
Study 2527244 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine (EPI)
Number of subjects: 26
Study 2527244 — intervention group
Group type: COMPARATOR
Intervention: No Epinephrine (no EPI)
Number of subjects: 26
Study 776040 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol tartrate
Number of subjects: 127
Study 776040 — intervention group
Group type: COMPARATOR
Intervention: Morphine sulfate
Number of subjects: 127
Study 30674610 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium abundance in early infancy
Number of subjects: 0
Study 30674610 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum subspecies infantis
Number of subjects: 0
Study 29212509 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose, high-frequency (LDHF) training
Number of subjects: 40
Study 25919644 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of finasteride (1.0 mg)
Number of subjects: 38
Study 24298760 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) applied at Qugu (CV 2), Zhongji (CV 3), Shuidao (ST 28), Qihai (CV 6), Guanyuan (CV 4), 5 times a week
Number of subjects: 204
Study 24298760 — intervention group
Group type: COMPARATOR
Intervention: Indwelling catheter applied at intervals of 2-4 hours with periodic bladder irrigation and rehabilitation training
Number of subjects: 204
Study 16087660 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid mixture (Vamin 18 g N/l)
Number of subjects: 6
Study 16087660 — intervention group
Group type: COMPARATOR
Intervention: Equicaloric glucose
Number of subjects: 6
Study 16087660 — intervention group
Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 6
Study 12932063 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil/Propofol
Number of subjects: 80
Study 12932063 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil/Isoflurane
Number of subjects: 80
Study 12932063 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil/Propofol and Remifentanil/Isoflurane
Number of subjects: 80
Study 10491213 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone specific alkaline phosphatase (BALP)
Number of subjects: 269
Study 10491213 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteocalcin (bone Gla protein, BGP)
Number of subjects: 269
Study 10491213 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridinoline (Pyr)
Number of subjects: 269
Study 10491213 — intervention group
Group type: EXPERIMENTAL
Intervention: Deoxypyridinoline (Dpyr)
Number of subjects: 269
Study 10491213 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT) measurements of cross-sectional areas of vertebrae and femurs
Number of subjects: 269
Study 10491213 — intervention group
Group type: EXPERIMENTAL
Intervention: Apparent density of cancellous bone in vertebrae
Number of subjects: 269
Study 10491213 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume and material density of cortical bone in femurs
Number of subjects: 269
Study 10491213 — intervention group
Group type: EXPERIMENTAL
Intervention: BALP and BGP
Number of subjects: 269
Study 10491213 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyr and Dpyr
Number of subjects: 269
Study 8700092 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle human touch (GHT) for 15 minutes a day from day 7 to day 12 of life
Number of subjects: 0
Study 1725539 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (sustained-release or conventional tablets)
Number of subjects: 15
Study 1725539 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem and captopril (combination therapy)
Number of subjects: 15
Study 1725539 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem with hydrochlorothiazide or atenolol (combination therapy)
Number of subjects: 15
Study 1725539 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 15
Study 1725539 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (monotherapy)
Number of subjects: 15
Study 6614298 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 10
Study 6614298 — intervention group
Group type: COMPARATOR
Intervention: Sterile saline
Number of subjects: 10
Study 31567875 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical presentation format for Genitourinary Syndrome of Menopause (GSM)
Number of subjects: 33
Study 31567875 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT) topic
Number of subjects: 33
Study 31567875 — intervention group
Group type: EXPERIMENTAL
Intervention: All formats of learning modules
Number of subjects: 33
Study 31567875 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered learning modules
Number of subjects: 33
Study 31567365 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study 31567365 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0
Study 31567365 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol and Sevoflurane
Number of subjects: 0
Study 29167052 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive behavior therapy (CBT) for SHA, 12 weeks
Number of subjects: 132
Study 29167052 — intervention group
Group type: COMPARATOR
Intervention: No treatment control condition
Number of subjects: 132
Study 25749132 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT) program, 6-week duration, 6 lessons using a Manga story
Number of subjects: 762
Study 25749132 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 762
Study 23727057 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdose of (14)C‐tolbutamide (100 μg)
Number of subjects: 0
Study 21367381 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Incision Laparoscopic Cholecystectomy (SILC)
Number of subjects: 83
Study 21367381 — intervention group
Group type: COMPARATOR
Intervention: Standard Laparoscopic Cholecystectomy (4PLC)
Number of subjects: 83
Study 19222929 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 weeks of antimicrobial therapy (2 weeks intravenous ceftriaxone and 2 weeks oral ciprofloxacin)
Number of subjects: 0
Study 19222929 — intervention group
Group type: COMPARATOR
Intervention: Chloramphenicol or ceftriaxone treatment (duration not specified)
Number of subjects: 0
Study 16554853 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline hydrochloride
Number of subjects: 147
Study 16554853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 12742869 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused group psychotherapy
Number of subjects: 360
Study 12742869 — intervention group
Group type: COMPARATOR
Intervention: Present-centered comparison treatment
Number of subjects: 360
Study 12742869 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused group therapy (adequate dose)
Number of subjects: 360
Study 12742869 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 360
Study 11196228 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement device
Number of subjects: 21
Study 11196228 — intervention group
Group type: COMPARATOR
Intervention: Control group (homologous control)
Number of subjects: 21
Study 8866262 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional glass‐ionomer liner under amalgam restorations
Number of subjects: 70
Study 8866262 — intervention group
Group type: EXPERIMENTAL
Intervention: Light‐cured glass‐ionomer liner placed 0.3 mm from the cavosurface margin under composite resin restoration
Number of subjects: 70
Study 8866262 — intervention group
Group type: COMPARATOR
Intervention: Two layers of copal varnish and amalgam
Number of subjects: 70
Study 8866262 — intervention group
Group type: COMPARATOR
Intervention: Light‐cured glass‐ionomer and amalgam
Number of subjects: 70
Study 8866262 — intervention group
Group type: COMPARATOR
Intervention: Bonding agent and light‐cured composite resin
Number of subjects: 70
Study 8866262 — intervention group
Group type: COMPARATOR
Intervention: Conventional glass‐ionomer, bonding agent and light‐cured composite resin
Number of subjects: 70
Study 8866262 — intervention group
Group type: COMPARATOR
Intervention: Light‐cured glass‐ionomer, extended 0.3 mm short of the enamel margin, bonding agent and light‐cured composite resin
Number of subjects: 70
Study 8866262 — intervention group
Group type: COMPARATOR
Intervention: Light‐cured glass‐ionomer, extended 1 mm short of the enamel margin, bonding agent and light‐cured composite resin
Number of subjects: 70
Study 1626042 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 12
Study 6389645 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training for 1 year
Number of subjects: 107
Study 6389645 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 107
Study 31335642 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (20 mg)
Number of subjects: 100
Study 31335642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 29764487 — intervention group
Group type: EXPERIMENTAL
Intervention: TPF (taxane, cisplatin, and 5-fluorouracil)
Number of subjects: 1879
Study 26930607 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK1070806 0.25 mg/kg
Number of subjects: 37
Study 26930607 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK1070806 5 mg/kg
Number of subjects: 37
Study 26930607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 24456510 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly monetary incentives for fitness-center attendance during fall semester
Number of subjects: 117
Study 24456510 — intervention group
Group type: COMPARATOR
Intervention: Discontinued-incentive condition (no incentives during spring semester)
Number of subjects: 117
Study 24456510 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued-incentive condition (variable-interval schedule during spring semester)
Number of subjects: 117
Study 22198821 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera leaf gel (300 mg capsule every 12 hours for 2 months)
Number of subjects: 30
Study 22198821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 20954664 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscoseal (hyaluronic acid) injection
Number of subjects: 56
Study 20954664 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 56
Study 18203570 — intervention group
Group type: EXPERIMENTAL
Intervention: INSIGHT therapy
Number of subjects: 0
Study 16355440 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of rhubarb extract (50 mg.kg(‐1))
Number of subjects: 8
Study 16355440 — intervention group
Group type: COMPARATOR
Intervention: Retention enema administration of rhubarb extract (50 mg.kg(‐1))
Number of subjects: 8
Study 16355440 — intervention group
Group type: EXPERIMENTAL
Intervention: Both oral and retention enema administration of rhubarb extract
Number of subjects: 8
Study 11867397 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric ropivacaine (25 mg in 8.3% glucose)
Number of subjects: 40
Study 11867397 — intervention group
Group type: COMPARATOR
Intervention: Plain ropivacaine (25 mg)
Number of subjects: 40
Study 9892302 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 422
Study 9892302 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 422
Study 7474676 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 0.1 mg/kg i.v. bolus, followed by 0.1 mg/kg/hr
Number of subjects: 6
Study 7474676 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-out water immersion (HOI)
Number of subjects: 6
Study 7474676 — intervention group
Group type: EXPERIMENTAL
Intervention: HOI during concomitant naloxone administration
Number of subjects: 6
Study 2180527 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital admission
Number of subjects: 77
Study 2180527 — intervention group
Group type: COMPARATOR
Intervention: Discharge home
Number of subjects: 77
Study 44770 — intervention group
Group type: EXPERIMENTAL
Intervention: Bunitrolol (Group A)
Number of subjects: 3
Study 44770 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscin-N-butyl-bromide and diazepam (Group B)
Number of subjects: 3
Study 44770 — intervention group
Group type: COMPARATOR
Intervention: No premedication (Group C)
Number of subjects: 3
Study 28385954 — intervention group
Group type: EXPERIMENTAL
Intervention: My Healthy Choices (intervention programme)
Number of subjects: 0
Study 28385954 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control
Number of subjects: 0
Study 28137634 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide administration in patients with NLR greater than 2 (group II)
Number of subjects: 64
Study 28137634 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide administration in patients with NLR less than 2 (group I)
Number of subjects: 64
Study 26506581 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX)
Number of subjects: 128
Study 26506581 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX) + Parent Training (PT)
Number of subjects: 128
Study 26506581 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo + Parent Training (PT)
Number of subjects: 128
Study 26506581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 24026159 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic therapy
Number of subjects: 183
Study 24026159 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 183
Study 20697967 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced workload (average census of 3.5 patients)
Number of subjects: 61
Study 20697967 — intervention group
Group type: COMPARATOR
Intervention: Typical workload (average census of 6.6 patients)
Number of subjects: 61
Study 20697967 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced workload
Number of subjects: 61
Study 20697967 — intervention group
Group type: COMPARATOR
Intervention: Typical workload
Number of subjects: 61
Study 19478228 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator
Number of subjects: 0
Study 17079090 — intervention group
Group type: EXPERIMENTAL
Intervention: Public service announcements with pictures and textual arguments
Number of subjects: 159
Study 17079090 — intervention group
Group type: EXPERIMENTAL
Intervention: Public service announcements with pictures only
Number of subjects: 159
Study 17079090 — intervention group
Group type: EXPERIMENTAL
Intervention: Public service announcements with textual arguments only
Number of subjects: 159
Study 17079090 — intervention group
Group type: COMPARATOR
Intervention: Public service announcements without pictures and textual arguments
Number of subjects: 159
Study 15366789 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 600 mg
Number of subjects: 86
Study 15366789 — intervention group
Group type: COMPARATOR
Intervention: Losartan 100 mg
Number of subjects: 86
Study 11710710 — intervention group
Group type: EXPERIMENTAL
Intervention: diacerein (50 mg twice a day)
Number of subjects: 507
Study 11710710 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 507
Study 9008377 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous income level (nonsalient condition)
Number of subjects: 0
Study 9008377 — intervention group
Group type: EXPERIMENTAL
Intervention: Income and work experience (salient condition)
Number of subjects: 0
Study 9008377 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined data from Study 1 and Study 2 (nonsalient condition)
Number of subjects: 0
Study 8331204 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin single oral doses (0.5 to 4.0 g)
Number of subjects: 24
Study 8331204 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin multiple oral doses (0.5 to 2.0 g every 12 hours)
Number of subjects: 24
Study 3579007 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant-load exercise tests above lactate threshold (LT)
Number of subjects: 6
Study 3579007 — intervention group
Group type: COMPARATOR
Intervention: Constant-load exercise tests below lactate threshold (LT)
Number of subjects: 6
Study 29751001 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (160 mg starting dose followed by 80 mg every 2 weeks, then 80 mg every 4 weeks during extension)
Number of subjects: 373
Study 29751001 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (in TE-ADA-positive patients)
Number of subjects: 373
Study 29751001 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (in TE-ADA-high titer group)
Number of subjects: 373
Study 29751001 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (overall efficacy)
Number of subjects: 373
Study 27621193 — intervention group
Group type: EXPERIMENTAL
Intervention: High PA diet (HPA)
Number of subjects: 12
Study 27621193 — intervention group
Group type: COMPARATOR
Intervention: Low PA and high OA diet (HOA)
Number of subjects: 12
Study 24122840 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol monotherapy
Number of subjects: 456
Study 24122840 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) monotherapy
Number of subjects: 456
Study 24122840 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy with atenolol and HCTZ
Number of subjects: 456
Study 23034421 — intervention group
Group type: EXPERIMENTAL
Intervention: At-home tray technique (5.0% H2O2)
Number of subjects: 30
Study 23034421 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-counter strip technique (5.3% H2O2)
Number of subjects: 30
Study 20879647 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative surgical flap (ASF)
Number of subjects: 33
Study 20879647 — intervention group
Group type: COMPARATOR
Intervention: Standard reverse L-flap (RLF)
Number of subjects: 33
Study 18194383 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed clamping of the umbilical cord (1 minute after delivery)
Number of subjects: 105
Study 18194383 — intervention group
Group type: COMPARATOR
Intervention: Immediate clamping of the umbilical cord
Number of subjects: 105
Study 16394615 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 76
Study 16394615 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary thrombolysis
Number of subjects: 76
Study 12093440 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral fiber‐containing nutrition with living Lactobacillus (group B)
Number of subjects: 90
Study 12093440 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral fiber‐containing nutrition with heat‐killed Lactobacillus (group C)
Number of subjects: 90
Study 12093440 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition or fiber‐free enteral nutrition (group A)
Number of subjects: 90
Study 12093440 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 12093440 — intervention group
Group type: EXPERIMENTAL
Intervention: Living Lactobacillus vs heat‐killed Lactobacillus
Number of subjects: 90
Study 10622071 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil 250 mg b.d.
Number of subjects: 0
Study 10622071 — intervention group
Group type: COMPARATOR
Intervention: Cefixime 200 mg b.d.
Number of subjects: 0
Study 8787257 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthetic (propofol for induction followed by propofol infusion)
Number of subjects: 235
Study 8787257 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intravenous‐inhalational anaesthetic (propofol with isoflurane in oxygen‐enriched air)
Number of subjects: 235
Study 8787257 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced inhalational anaesthetic (thiopentone for induction and oxygen in nitrous oxide with isoflurane for maintenance)
Number of subjects: 235
Study 2025840 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniospinal irradiation plus a local boost (CS‐XRT)
Number of subjects: 17
Study 2025840 — intervention group
Group type: COMPARATOR
Intervention: Local irradiation only (L‐XRT)
Number of subjects: 17
Study 2025840 — intervention group
Group type: COMPARATOR
Intervention: No irradiation (NRT)
Number of subjects: 17
Study 2025840 — intervention group
Group type: COMPARATOR
Intervention: Age < 4 years at diagnosis
Number of subjects: 17
Study 2025840 — intervention group
Group type: COMPARATOR
Intervention: Age > 4 years at diagnosis
Number of subjects: 17
Study 2025840 — intervention group
Group type: COMPARATOR
Intervention: Local radiation doses over 4500 cGy
Number of subjects: 17
Study 2025840 — intervention group
Group type: COMPARATOR
Intervention: Local radiation doses less than 4500 cGy
Number of subjects: 17
Study 7282308 — intervention group
Group type: COMPARATOR
Intervention: BFTZ + P
Number of subjects: 97
Study 7282308 — intervention group
Group type: EXPERIMENTAL
Intervention: E/N
Number of subjects: 97
Study 7282308 — intervention group
Group type: EXPERIMENTAL
Intervention: BFTZ + E/N
Number of subjects: 97
Study 6465150 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated bedside dispensing machine (McLaughlin Dispensing System)
Number of subjects: 32